Maryland Matters
Danielle J. Brown
January 19, 2024


“The Number One argument that drug corporations make against our proposal is that if we do this, they won’t be able to afford to do their research,” DeMarco said.

“They have the money right now to do all the research they need,” he said. “They’re not spending it on research, they’re spending more of it on profits and advertising. So we need to do what we can to make high costs drugs more affordable.”

Read the full article at

Last modified: January 25, 2024